Table 4 Univariate logistic regression models for mortality in children with moderate-to-severe ARDS and hematologic or immune-related diseases

Sex (Male)

0.796

1.145

0.409–3.210

Age<6 years old

0.039

3.100

1.062–9.052

Weight

0.258

0.978

0.940–1.017

PIM3

0.310

2.072

0.507–8.468

PELOD2

0.035

1.136

1.009–1.279

OI

0.146

1.043

0.985–1.104

Sever PARDS

0.141

2.211

0.768–6.360

PID

0.957

1.032

0.327–3.263

Leukemia

0.300

1.950

0.551–6.901

Lymphoma

0.202

4.083

0.469–35.524

Septic Shock

0.045

3.562

1.032–12.303

Neutropenia

0.096

2.692

0.840–8.627

Invasive Fungal Infections

0.022

3.910

1.222–12.514

Hematopoietic Stem Cell Transplantation

0.505

2.154

0.226–20.529

WBC

0.288

1.016

0.987–1.046

PCT

0.191

1.161

0.928–1.454

Creatine

0.681

0.998

0.988–1.008

Lactate, mmol/L

0.691

1.102

0.684–1.774

PaO2, mmHg

0.845

0.998

0.976–1.020

PaCO2, mmHg

0.482

1.010

0.982–1.039

Glu, mmol/L

0.315

0.940

0.833–1.060

Positive Blood Pathogen

0.617

0.758

0.256–2.245

Positive Sputum Pathogen

0.392

0.574

0.161–2.048

MV>7

0.796

0.873

0.312–2.446

HFOV

0.031

3.913

1.135–13.496

Length of HFOV

0.417

1.100

0.874–1.383

Pulmonary Vasodilators

0.702

1.575

0.154–16.091

Neuromuscular Blocking Agents

0.575

0.617

0.114–3.343

Prone Ventilation

0.615

1.448

0.343–6.108

Systemic Steroid

0.093

0.382

0.124–1.176

β-Receptor Agonist

0.941

1.040

0.366–2.953

Diuretic

0.248

2.235

0.571–8.754

Blood Transfusion

0.027

3.333

1.143–9.722

Intravenous Immunoglobulin

0.111

3.057

0.773–12.088

CRRT

0.202

4.083

0.469–35.524

Vasopressor

0.002

8.125

2.154–30.654

Parenteral Nutrition

0.816

0.833

0.180–3.863